Detalhe da pesquisa
1.
OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.
Can J Neurol Sci
; 50(3): 418-427, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466897
2.
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.
Can J Neurol Sci
; 49(4): 540-552, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218836
3.
Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe.
Can J Neurol Sci
; 48(5): 676-684, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342445
4.
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study.
Can J Neurol Sci
; 46(6): 742-752, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31256770
5.
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM.
Can J Neurol Sci
; 51(1): 149, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105013
6.
Reoperation Rate After Primary Augmentation With Smooth, Textured, High Fill, Cohesive, Round Breast Implants (RANBI-I Study).
Aesthet Surg J
; 39(12): 1342-1349, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383228
7.
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.
Can J Neurol Sci
; 43(5): 687-96, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27430524
8.
Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.
Dermatol Surg
; 42(3): 410-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863598
9.
Cryolipolysis of the Arms and Inner Thighs Shows Similar Treatment Outcomes in Chinese Individuals Compared to White Individuals Treated in a Prior Study: The XinCOOL Study.
Aesthet Surg J Open Forum
; 5: ojad103, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108021
10.
Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey.
Can J Neurol Sci
; 38(5): 704-11, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856572
11.
Validation of internal controls for gene expression analysis in the intestine of rats infected with Hymenolepis diminuta.
Parasitol Int
; 56(4): 325-9, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17669683
12.
An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial.
Clin Ophthalmol
; 8: 1031-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24920879
13.
An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial.
Clin Ophthalmol
; 6: 2097-103, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269858